Monday , December 11 2023

Cell Expansion Market Forecast

Cell Expansion Market

The global cell expansion market is experiencing remarkable growth, with projections indicating that it will reach a staggering $30.1 billion by 2025. This growth, characterized by a compound annual growth rate (CAGR) of 15.1% from 2020 to 2025, is driven by several key factors, including the increasing prevalence of chronic diseases, significant government investments in cell-based research, a growing emphasis on personalized medicine, expanding research and development initiatives for cell-based therapies, and the rising number of Good Manufacturing Practice (GMP) certifications for cell therapy production facilities.

Download PDF Brochure-

Cell Expansion Market Dynamics

Drivers: Increasing Incidence of Chronic Diseases

One of the primary drivers propelling the cell expansion market is the growing incidence of chronic diseases worldwide. Cell expansion plays a pivotal role in the research and development of drugs for treating various diseases, including diabetes and cancer. The International Diabetes Federation (IDF) reported approximately 425 million people with diabetes in 2017, and this number is expected to reach a staggering 629 million by 2045. Cancer, now the leading global cause of death, claimed 9.6 million lives in 2018, with projections indicating an increase to approximately 30 million cases by 2040 from 18 million in 2018. These alarming statistics underscore the urgent need for extensive research into the diagnosis and treatment of these diseases, with cell expansion forming a critical component of this research effort.

Restraints: Ethical Concerns in Cell Biology Research

While cell biology research offers great promise, ethical concerns have arisen regarding the use of animals and human cells in such studies. These cells are crucial for gene therapy studies, stem cell research therapies, in vivo toxicity testing of drugs, and other research endeavors. However, the utilization of these cells may harm animals and humans. To address these ethical concerns, stringent regulations have been implemented by various global authorities, including the Human Tissue Authority (HTA), Human Fertilization and Embryology Authority (HFEA), Medicines and Healthcare products Regulatory Agency (MHRA), and Central Ethics Committee for Stem Cell Research (ZES), among others. These regulations restrict cell biology research in several countries, potentially hindering the global market’s growth.

Opportunities: Emerging Markets

Emerging markets are poised to play a pivotal role in the cell expansion market’s growth. Countries like India, Brazil, and China have witnessed substantial growth in their biotechnology and pharmaceutical industries in recent years, a trend expected to persist in the forecast period. India’s biotechnology industry, for instance, is projected to reach USD 100 billion by 2025, up from USD 11 billion in 2016, with the pharmaceutical industry expected to reach USD 55 billion by 2020. Brazil’s pharmaceuticals market is also expected to grow from USD 25.3 billion in 2016 to USD 29.9 billion by 2021. This growth in biotechnology and pharmaceutical industries is likely to boost demand for cell expansion products, both for research and the production of pharmaceuticals.

Segmentation Analysis

By Product, Consumables Lead the Way

In terms of product segmentation, the consumables segment holds the largest share of the cell expansion market. This segment includes reagents, media, sera, and disposables, while instruments encompass cell expansion supporting equipment, bioreactors, and automated cell expansion systems. In 2019, consumables dominated the market due to increased vaccine and biologics production in the biopharmaceutical and biotechnology sectors.

By Application, Regenerative Medicine and Stem Cell Research Lead

The market is further segmented by application, with regenerative medicine and stem cell research claiming the largest share in 2019. This dominance is attributed to increased funding for regenerative medicine and stem cell research initiatives.

By Cell Type, Human Cells Dominate

In the cell type segment, human cells, including stem cells and differentiated cells, outpace animal cells. Human cells include adult stem cells, embryonic stem cells (ESCs), and induced pluripotent stem cells (iPSCs). The preference for human cells is driven by heightened investments in human cell research, expanding application areas for human stem cells, and the growing incidence of diseases such as cancer.

Regional Insights

North America takes the lead in the cell expansion market, boasting the largest market share in 2019. Several factors contribute to this dominance, including the rising incidence of cancer, increased government funding, expanding research activities focusing on stem cell therapies, growing awareness of advanced treatment methods, a growing geriatric population, and the presence of key industry players in the region.

Key Players in the Global Cell Expansion Market

The global cell expansion market is shaped by a select group of well-established players and promising start-ups. Notable industry leaders include Thermo Fisher Scientific, Danaher, Becton, Dickinson and Company, Lonza, Corning, Merck, Miltenyi Biotec, STEMCELL Technologies Inc., Sartorius Stedim Biotech, and Terumo. Start-up companies like REPROCELL, iXCells Biotechnologies, Neuromics, G&G Technologies, and Celltainer Biotech are also contributing to the market’s growth and innovation.

Download PDF Brochure-

In conclusion, the global cell expansion market is on an upward trajectory, driven by factors like the increasing prevalence of chronic diseases, ethical considerations in cell biology research, and emerging markets’ potential. As the market continues to evolve, it presents numerous opportunities for industry players to advance research, develop therapies, and contribute to the future of medicine.

Check Also

Oxygen Concentrators Market: Medical Advances, Respiratory Solutions, and Homecare Innovations 2029.

Oxygen Concentrators Market: is expected to reach US$ 2.66 Bn. at a CAGR of 3.5 % during …

Leave a Reply

Your email address will not be published. Required fields are marked *